These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10837447)

  • 21. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.
    Maeyama Y; Taniguchi Y; Hayashi W; Ohsaki Y; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
    Vet Microbiol; 2018 Mar; 216():183-189. PubMed ID: 29519514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges.
    Iregui A; Ha K; Meleney K; Landman D; Quale J
    J Antimicrob Chemother; 2018 Nov; 73(11):2997-3000. PubMed ID: 30107491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
    Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
    Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital.
    Dahmen S; Bettaieb D; Mansour W; Boujaafar N; Bouallègue O; Arlet G
    Microb Drug Resist; 2010 Jun; 16(2):163-70. PubMed ID: 20438347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESBL expression and antibiotic resistance patterns in a hospital in Saudi Arabia: Do healthcare staff have the whole picture?
    Aldrazi FA; Rabaan AA; Alsuliman SA; Aldrazi HA; Alabdalslam MJ; Alsadiq SA; Alhani HM; Bueid AS
    J Infect Public Health; 2020 May; 13(5):759-766. PubMed ID: 31901487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The occurrence of CTX-M-25-producing Enterobacteriaceae in day-old broiler chicks in Japan.
    Yossapol M; Sugiyama M; Asai T
    J Vet Med Sci; 2017 Oct; 79(10):1644-1647. PubMed ID: 28781343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.
    Rodríguez-Baño J; Miró E; Villar M; Coelho A; Gozalo M; Borrell N; Bou G; Conejo MC; Pomar V; Aracil B; Larrosa N; Agüero J; Oliver A; Fernández A; Oteo J; Pascual A; Navarro F
    J Infect; 2012 Feb; 64(2):176-83. PubMed ID: 22138600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital.
    Hassan H; Abdalhamid B
    J Infect Dev Ctries; 2014 Mar; 8(3):282-8. PubMed ID: 24619257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
    Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
    Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid-mediated quinolone resistance among extended spectrum beta lactase producing Enterobacteriaceae from bloodstream infections.
    Domokos J; Kristóf K; Szabó D
    Acta Microbiol Immunol Hung; 2016 Sep; 63(3):313-323. PubMed ID: 27539331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of extended-spectrum beta-lactamases and drug sensitivity test in clinical isolates of the family Enterobacteriaceae in Shanghai].
    Lin Q; Luo W; Xiu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):420-2. PubMed ID: 11778509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of a citywide outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection.
    Quale JM; Landman D; Bradford PA; Visalli M; Ravishankar J; Flores C; Mayorga D; Vangala K; Adedeji A
    Clin Infect Dis; 2002 Oct; 35(7):834-41. PubMed ID: 12228820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
    J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
    Uemura M; Imataki O; Uchida S; Nakayama-Imaohji H; Ohue Y; Matsuka H; Mori H; Dobashi H; Kuwahara T; Kadowaki N
    BMC Infect Dis; 2017 Jan; 17(1):26. PubMed ID: 28056827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes].
    Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C
    Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.
    Castanheira M; Mills JC; Costello SE; Jones RN; Sader HS
    Antimicrob Agents Chemother; 2015; 59(6):3509-17. PubMed ID: 25845862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.